Do you want to be part of the stem cell revolution?

Advanced cell therapy treatments offer the opportunity to transform healthcare as we know it. But the development is dependent on donations. Donate cells and be the first step in a life-changing journey. Donors need to be healthy and 18-28 years old.


Your cells make a real impact

Advanced cell therapy treatments offer people with chronic or terminal diseases a chance for a brighter future. But they rely on donations.

A single donation can treat hundreds of patients. Furthermore, MSC don’t require HLA-typing, meaning that your cells can be donated to any patient without worrying about matching. Your cells are therefore extremely useful.

We recognize your contribution

Donating bone marrow - the source of the MSC - means that you will receive a comprehensive health check-up and be compensated for loss of income. Transport is included. We are happy to invite recurring donors interested in the field to our production facility and meet the team.

Donating bone marrow is easy

Donating bone marrow begins with a blood test and 1-hour physical screening in central Stockholm. This is followed by a 2-hour visit for the donation. The donation takes less than 30 minutes and you receive local anaesthetics in the back of the hip. After some fika you can return to your regular daily activities. Enter the form below and our nurse will contact you for further information.

Disrupting treatments for a wide range of diseases

MSC have the potential to cure or prevent many conditions and chronic diseases. Research is conducted within the following fields, among many others.

  • Systemic inflammatory diseases
  • Type 1 diabetes
  • Acute kidney injury
  • Parkinson's disease
  • Stroke
  • Wound healing
  • Spinal cord injury
  • Graft versus host disease
  • Cardiovascular diseases
  • Aging frailty
  • Alzheimer's disease
  • Multiple sclerosis
  • Arthritis (OA and RA)
  • Orthopedic injuries

Looking for treatments?

Cellcolabs does not provide treatments directly. However, we can provide updates on how and when it is possible to join the clinical studies that we sponsor or partner with in coming years.

For patients